Immucor CE marks HEA BeadChip for blood testing
This article was originally published in Clinica
Executive Summary
Immucor has CE marked its Human Erythrocyte Antigen (HEA) BeadChip kit. The product is designed for DNA testing of blood before transfusion, which the firm believes will improve matching of patient and donor blood, and therefore safety. The HEA BeadChip uses multiplex DNA analysis to perform extended typing of 32 red blood cell antigens simultaneously. The assay was originally developed by BioArray, which Norcross, Georgia-based Immucor acquired in 2008. The company has already CE marked its Human Platelet Antigen (HPA) assay, which is used for platelet genotyping, and the Array Imaging System, to read and interpret test results.